MCC (01618) Income Statement & Earnings

1.540
-0.020-1.28%

Market Closed May 15 16:01 CST

31.91BMarket Cap20.81P/E (TTM)

MCC (01618) Income Statement

All

YOY

Hide blank lines

(Q1)Mar 31, 2026

(FY)Dec 31, 2025

(Q9)Sep 30, 2025

(Q6)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

Turnover

-24.59%92.2B

-17.51%455.38B

-18.79%335.09B

-20.52%237.53B

-18.46%122.27B

-12.91%552.02B

-11.71%412.62B

-10.65%298.84B

3.81%149.95B

6.95%633.87B

Operating income

-24.59%92.2B

-17.51%455.38B

-18.79%335.09B

-20.52%237.53B

-18.46%122.27B

-12.91%552.02B

-11.71%412.62B

-10.65%298.84B

3.81%149.95B

6.95%633.87B

Operating expenses

24.40%-84.27B

17.87%-409.45B

19.64%-301.6B

21.43%-213.56B

19.04%-111.47B

12.91%-498.54B

11.53%-375.3B

10.44%-271.8B

-5.25%-137.67B

-6.90%-572.46B

Gross profit

-26.60%7.93B

-14.11%45.93B

-10.24%33.5B

-11.36%23.97B

-11.98%10.8B

-12.92%53.48B

-13.43%37.32B

-12.74%27.04B

-10.04%12.27B

7.46%61.41B

Selling expenses

14.70%-562.42M

1.28%-3.02B

7.98%-1.86B

5.94%-1.3B

5.75%-659.37M

3.34%-3.06B

-0.42%-2.02B

0.43%-1.39B

-6.35%-699.61M

-9.93%-3.17B

Administrative expenses

11.90%-2.67B

2.94%-11.48B

5.43%-7.79B

6.58%-5.33B

4.93%-3.03B

4.29%-11.83B

-1.85%-8.23B

-5.21%-5.71B

-3.76%-3.19B

-9.64%-12.36B

Research and development expenses

33.84%-1.85B

14.89%-13.96B

16.29%-9.96B

16.50%-6.73B

0.63%-2.8B

16.85%-16.41B

12.09%-11.9B

11.25%-8.07B

-0.11%-2.82B

-5.33%-19.73B

Profit from asset sales

-80.71%2.01M

-65.36%364.63M

-80.85%192.11M

-78.92%178.67M

-92.96%10.4M

58.76%1.05B

1,856.49%1B

2,395.55%847.46M

832.47%147.71M

118.58%663.08M

Revaluation surplus

143.72%25.38M

91.86%-30.72M

69.32%-22.73M

79.37%-44.68M

68.43%-58.05M

-20.04%-377.21M

83.85%-74.08M

34.04%-216.6M

-5,553.63%-183.86M

1.12%-314.22M

-Changes in the fair value of other assets

143.72%25.38M

91.86%-30.72M

69.32%-22.73M

79.37%-44.68M

68.43%-58.05M

-20.04%-377.21M

83.85%-74.08M

34.04%-216.6M

-5,553.63%-183.86M

1.12%-314.22M

Impairment and provision

118.44%170.26M

-184.08%-27.65B

5.63%-4.06B

25.90%-3.61B

-0.80%-923.1M

-8.77%-9.73B

-7.05%-4.3B

-57.88%-4.87B

-0.46%-915.76M

-80.37%-8.95B

-Other impairment is provision

118.44%170.26M

-184.08%-27.65B

5.63%-4.06B

25.90%-3.61B

-0.80%-923.1M

-8.77%-9.73B

-7.05%-4.3B

-57.88%-4.87B

-0.46%-915.76M

-80.37%-8.95B

Special items of operating profit

124.42%11.7M

2,427.82%18.72B

-44.22%-561.27M

41.41%-206.1M

68.12%-47.93M

13.26%-804.3M

24.12%-389.18M

30.58%-351.75M

37.38%-150.35M

14.93%-927.25M

Operating profit

-6.13%2.76B

-39.14%6.18B

-17.27%8.21B

-5.32%6.04B

-28.29%2.94B

-30.90%10.16B

-24.63%9.93B

-37.45%6.38B

-25.39%4.1B

-9.93%14.7B

Financing income

74.21%518.98M

27.13%3.45B

1.01%1.47B

-3.75%937.17M

-6.02%297.9M

35.68%2.72B

47.18%1.46B

0.48%973.65M

-11.44%316.97M

-17.41%2B

Financing cost

-22.96%-665.81M

-7.71%-3.65B

-12.99%-2.16B

-9.89%-1.44B

-30.99%-541.46M

-28.35%-3.39B

-16.34%-1.91B

5.42%-1.31B

-47.40%-413.37M

-0.39%-2.64B

Special items of earning before tax

463.04%70.45M

-208.08%-185.5M

-1,775.03%-88.46M

85.52%-9.19M

-4.76%12.51M

250.74%171.64M

-116.22%-4.72M

-12.95%-63.46M

-55.61%13.14M

576.18%48.94M

Earning before tax

-9.10%2.37B

-45.87%5.01B

-21.26%7.02B

-7.08%5.28B

-32.95%2.61B

-32.77%9.25B

-29.71%8.92B

-42.61%5.68B

-27.05%3.89B

-10.57%13.76B

After-tax profit from continuing operations

-22.37%1.97B

-27.23%7.71B

-30.01%5.39B

-13.35%4.07B

-19.16%2.54B

-7.09%10.6B

-26.67%7.7B

-45.84%4.7B

-28.34%3.14B

-11.80%11.41B

After-tax profit from non-continuing business

----

-92.73%-5.19B

----

---467.03M

---2.69B

----

Earning after tax

-4.90%1.97B

-68.09%2.52B

-30.01%5.39B

-13.35%4.07B

-34.01%2.08B

-30.70%7.9B

-26.67%7.7B

-45.84%4.7B

-28.34%3.14B

-11.80%11.41B

Minority profit

-27.16%340.89M

3.62%1.2B

63.30%1.42B

76.75%973.71M

0.39%468M

-57.66%1.16B

-62.49%868.48M

-62.30%550.89M

-54.16%466.2M

3.02%2.74B

Profit attributable to shareholders

1.59%1.63B

-80.41%1.32B

-41.88%3.97B

-25.31%3.1B

-40.00%1.61B

-22.20%6.75B

-16.53%6.83B

-42.50%4.15B

-20.56%2.68B

-15.63%8.67B

Basic earnings per share

0.00%0.08

-99.15%0.002

-45.83%0.13

-18.18%0.09

-33.33%0.08

-28.48%0.236

-22.58%0.24

-57.69%0.11

-20.00%0.12

-26.67%0.33

Diluted earnings per share

0.00%0.08

-99.15%0.002

-45.83%0.13

-18.18%0.09

-33.33%0.08

-28.48%0.236

-22.58%0.24

-57.69%0.11

-20.00%0.12

-26.67%0.33

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified Opinion

Auditor

Deloitte Touche Tohmatsu Certified Public Accountants (Special General Partnership)

Ernst & Young Huaming Accounting Firm (Special General Partnership)

	(Q1)Mar 31, 2026	(FY)Dec 31, 2025	(Q9)Sep 30, 2025	(Q6)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023
Turnover	-24.59%92.2B	-17.51%455.38B	-18.79%335.09B	-20.52%237.53B	-18.46%122.27B	-12.91%552.02B	-11.71%412.62B	-10.65%298.84B	3.81%149.95B	6.95%633.87B
Operating income	-24.59%92.2B	-17.51%455.38B	-18.79%335.09B	-20.52%237.53B	-18.46%122.27B	-12.91%552.02B	-11.71%412.62B	-10.65%298.84B	3.81%149.95B	6.95%633.87B
Operating expenses	24.40%-84.27B	17.87%-409.45B	19.64%-301.6B	21.43%-213.56B	19.04%-111.47B	12.91%-498.54B	11.53%-375.3B	10.44%-271.8B	-5.25%-137.67B	-6.90%-572.46B
Gross profit	-26.60%7.93B	-14.11%45.93B	-10.24%33.5B	-11.36%23.97B	-11.98%10.8B	-12.92%53.48B	-13.43%37.32B	-12.74%27.04B	-10.04%12.27B	7.46%61.41B
Selling expenses	14.70%-562.42M	1.28%-3.02B	7.98%-1.86B	5.94%-1.3B	5.75%-659.37M	3.34%-3.06B	-0.42%-2.02B	0.43%-1.39B	-6.35%-699.61M	-9.93%-3.17B
Administrative expenses	11.90%-2.67B	2.94%-11.48B	5.43%-7.79B	6.58%-5.33B	4.93%-3.03B	4.29%-11.83B	-1.85%-8.23B	-5.21%-5.71B	-3.76%-3.19B	-9.64%-12.36B
Research and development expenses	33.84%-1.85B	14.89%-13.96B	16.29%-9.96B	16.50%-6.73B	0.63%-2.8B	16.85%-16.41B	12.09%-11.9B	11.25%-8.07B	-0.11%-2.82B	-5.33%-19.73B
Profit from asset sales	-80.71%2.01M	-65.36%364.63M	-80.85%192.11M	-78.92%178.67M	-92.96%10.4M	58.76%1.05B	1,856.49%1B	2,395.55%847.46M	832.47%147.71M	118.58%663.08M
Revaluation surplus	143.72%25.38M	91.86%-30.72M	69.32%-22.73M	79.37%-44.68M	68.43%-58.05M	-20.04%-377.21M	83.85%-74.08M	34.04%-216.6M	-5,553.63%-183.86M	1.12%-314.22M
-Changes in the fair value of other assets	143.72%25.38M	91.86%-30.72M	69.32%-22.73M	79.37%-44.68M	68.43%-58.05M	-20.04%-377.21M	83.85%-74.08M	34.04%-216.6M	-5,553.63%-183.86M	1.12%-314.22M
Impairment and provision	118.44%170.26M	-184.08%-27.65B	5.63%-4.06B	25.90%-3.61B	-0.80%-923.1M	-8.77%-9.73B	-7.05%-4.3B	-57.88%-4.87B	-0.46%-915.76M	-80.37%-8.95B
-Other impairment is provision	118.44%170.26M	-184.08%-27.65B	5.63%-4.06B	25.90%-3.61B	-0.80%-923.1M	-8.77%-9.73B	-7.05%-4.3B	-57.88%-4.87B	-0.46%-915.76M	-80.37%-8.95B
Special items of operating profit	124.42%11.7M	2,427.82%18.72B	-44.22%-561.27M	41.41%-206.1M	68.12%-47.93M	13.26%-804.3M	24.12%-389.18M	30.58%-351.75M	37.38%-150.35M	14.93%-927.25M
Operating profit	-6.13%2.76B	-39.14%6.18B	-17.27%8.21B	-5.32%6.04B	-28.29%2.94B	-30.90%10.16B	-24.63%9.93B	-37.45%6.38B	-25.39%4.1B	-9.93%14.7B
Financing income	74.21%518.98M	27.13%3.45B	1.01%1.47B	-3.75%937.17M	-6.02%297.9M	35.68%2.72B	47.18%1.46B	0.48%973.65M	-11.44%316.97M	-17.41%2B
Financing cost	-22.96%-665.81M	-7.71%-3.65B	-12.99%-2.16B	-9.89%-1.44B	-30.99%-541.46M	-28.35%-3.39B	-16.34%-1.91B	5.42%-1.31B	-47.40%-413.37M	-0.39%-2.64B
Special items of earning before tax	463.04%70.45M	-208.08%-185.5M	-1,775.03%-88.46M	85.52%-9.19M	-4.76%12.51M	250.74%171.64M	-116.22%-4.72M	-12.95%-63.46M	-55.61%13.14M	576.18%48.94M
Earning before tax	-9.10%2.37B	-45.87%5.01B	-21.26%7.02B	-7.08%5.28B	-32.95%2.61B	-32.77%9.25B	-29.71%8.92B	-42.61%5.68B	-27.05%3.89B	-10.57%13.76B
After-tax profit from continuing operations	-22.37%1.97B	-27.23%7.71B	-30.01%5.39B	-13.35%4.07B	-19.16%2.54B	-7.09%10.6B	-26.67%7.7B	-45.84%4.7B	-28.34%3.14B	-11.80%11.41B
After-tax profit from non-continuing business	----	-92.73%-5.19B	----	----	---467.03M	---2.69B	----	----	----	----
Earning after tax	-4.90%1.97B	-68.09%2.52B	-30.01%5.39B	-13.35%4.07B	-34.01%2.08B	-30.70%7.9B	-26.67%7.7B	-45.84%4.7B	-28.34%3.14B	-11.80%11.41B
Minority profit	-27.16%340.89M	3.62%1.2B	63.30%1.42B	76.75%973.71M	0.39%468M	-57.66%1.16B	-62.49%868.48M	-62.30%550.89M	-54.16%466.2M	3.02%2.74B
Profit attributable to shareholders	1.59%1.63B	-80.41%1.32B	-41.88%3.97B	-25.31%3.1B	-40.00%1.61B	-22.20%6.75B	-16.53%6.83B	-42.50%4.15B	-20.56%2.68B	-15.63%8.67B
Basic earnings per share	0.00%0.08	-99.15%0.002	-45.83%0.13	-18.18%0.09	-33.33%0.08	-28.48%0.236	-22.58%0.24	-57.69%0.11	-20.00%0.12	-26.67%0.33
Diluted earnings per share	0.00%0.08	-99.15%0.002	-45.83%0.13	-18.18%0.09	-33.33%0.08	-28.48%0.236	-22.58%0.24	-57.69%0.11	-20.00%0.12	-26.67%0.33
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	Unqualified Opinion	--	--	--	Unqualified Opinion	--	--	--	Unqualified Opinion
Auditor	--	Deloitte Touche Tohmatsu Certified Public Accountants (Special General Partnership)	--	--	--	Ernst & Young Huaming Accounting Firm (Special General Partnership)	--	--	--	Ernst & Young Huaming Accounting Firm (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More

牛牛課堂

Oct 13, 2025 18:05

[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?

Food流油

Apr 14, 2025 15:43

"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"